Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Infectivity and insertional mutagenesis of endogenous retrovirus in autoimmune NZB and B/W mice.

Beck-Engeser GB, Ahrends T, Knittel G, Wabl R, Metzner M, Eilat D, Wabl M.

J Gen Virol. 2015 Nov;96(11):3396-410. doi: 10.1099/jgv.0.000271. Epub 2015 Aug 26.

2.

APOBEC3 enzymes restrict marginal zone B cells.

Beck-Engeser GB, Winkelmann R, Wheeler ML, Shansab M, Yu P, Wünsche S, Walchhütter A, Metzner M, Vettermann C, Eilat D, DeFranco A, Jäck HM, Wabl M.

Eur J Immunol. 2015 Mar;45(3):695-704. doi: 10.1002/eji.201445218. Epub 2015 Jan 21.

3.

Insertional hypermutation in mineral oil-induced plasmacytomas.

Knittel G, Metzner M, Beck-Engeser G, Kan A, Ahrends T, Eilat D, Huppi K, Wabl M.

Eur J Immunol. 2014 Sep;44(9):2785-801. doi: 10.1002/eji.201344322.

4.

Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors.

Sokol M, Wabl M, Ruiz IR, Pedersen FS.

Retrovirology. 2014 May 19;11:36. doi: 10.1186/1742-4690-11-36.

5.

Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes.

Dabrowska MJ, Ejegod D, Lassen LB, Johnsen HE, Wabl M, Pedersen FS, Dybkær K.

Leuk Res. 2013 Oct;37(10):1383-90. doi: 10.1016/j.leukres.2013.04.012. Epub 2013 Jul 26.

6.

Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.

Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M, Harvey RC, Govern C, Bakker J, Lenstra TL, Ammon K, Boeter A, Winter SS, Loh M, Shannon K, Chakraborty AK, Wabl M, Roose JP.

Sci Signal. 2013 Mar 26;6(268):ra21. doi: 10.1126/scisignal.2003848.

7.

LINE-1 retroelements complexed and inhibited by activation induced cytidine deaminase.

Metzner M, Jäck HM, Wabl M.

PLoS One. 2012;7(11):e49358. doi: 10.1371/journal.pone.0049358. Epub 2012 Nov 2.

8.

B cell tolerance and positive selection in lupus.

Eilat D, Wabl M.

J Immunol. 2012 Jul 15;189(2):503-9. doi: 10.4049/jimmunol.1200848.

9.

Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease.

Chen H, Hayashi G, Lai OY, Dilthey A, Kuebler PJ, Wong TV, Martin MP, Fernandez Vina MA, McVean G, Wabl M, Leslie KS, Maurer T, Martin JN, Deeks SG, Carrington M, Bowcock AM, Nixon DF, Liao W.

PLoS Genet. 2012 Feb;8(2):e1002514. doi: 10.1371/journal.pgen.1002514. Epub 2012 Feb 16.

10.

Sequential class switching is required for the generation of high affinity IgE antibodies.

Xiong H, Dolpady J, Wabl M, Curotto de Lafaille MA, Lafaille JJ.

J Exp Med. 2012 Feb 13;209(2):353-64. doi: 10.1084/jem.20111941. Epub 2012 Jan 16.

11.

An autoimmune disease prevented by anti-retroviral drugs.

Beck-Engeser GB, Eilat D, Wabl M.

Retrovirology. 2011 Nov 8;8:91. doi: 10.1186/1742-4690-8-91.

12.

CD22 serves as a receptor for soluble IgM.

Adachi T, Harumiya S, Takematsu H, Kozutsumi Y, Wabl M, Fujimoto M, Tedder TF.

Eur J Immunol. 2012 Jan;42(1):241-7. doi: 10.1002/eji.201141899. Epub 2011 Nov 10.

13.

Pro-B cells sense productive immunoglobulin heavy chain rearrangement irrespective of polypeptide production.

Lutz J, Heideman MR, Roth E, van den Berk P, Müller W, Raman C, Wabl M, Jacobs H, Jäck HM.

Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10644-9. doi: 10.1073/pnas.1019224108. Epub 2011 Jun 13.

14.

Overbuilding: overhead revisions.

Wabl M.

Science. 2010 Nov 19;330(6007):1045-7. doi: 10.1126/science.330.6007.1045-c. No abstract available.

PMID:
21097917
15.
16.

Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer.

Lum AM, Wang BB, Beck-Engeser GB, Li L, Channa N, Wabl M.

BMC Cancer. 2010 Feb 11;10:40. doi: 10.1186/1471-2407-10-40.

17.

Two forms of activation-induced cytidine deaminase differing in their ability to bind agarose.

Metzner M, Schuh W, Roth E, Jäck HM, Wabl M.

PLoS One. 2010 Jan 27;5(1):e8883. doi: 10.1371/journal.pone.0008883.

18.

Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir.

Beck-Engeser GB, Eilat D, Harrer T, Jäck HM, Wabl M.

Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20865-70. doi: 10.1073/pnas.0908074106. Epub 2009 Nov 18.

19.

Activation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesis.

Rasmussen MH, Wang B, Wabl M, Nielsen AL, Pedersen FS.

Nucleic Acids Res. 2009 Aug;37(14):4657-71. doi: 10.1093/nar/gkp469. Epub 2009 Jun 5.

20.

Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1.

Dabrowska MJ, Dybkaer K, Johnsen HE, Wang B, Wabl M, Pedersen FS.

J Virol. 2009 Aug;83(16):8051-61. doi: 10.1128/JVI.00427-09. Epub 2009 May 27.

21.

Activation of the brain-specific neurogranin gene in murine T-cell lymphomas by proviral insertional mutagenesis.

Nielsen AA, Kjartansdóttir KR, Rasmussen MH, Sørensen AB, Wang B, Wabl M, Pedersen FS.

Gene. 2009 Aug 1;442(1-2):55-62. doi: 10.1016/j.gene.2009.04.003. Epub 2009 Apr 17.

22.

Identification of novel Bach2 transcripts and protein isoforms through tagging analysis of retroviral integrations in B-cell lymphomas.

Liu J, Sørensen AB, Wang B, Wabl M, Nielsen AL, Pedersen FS.

BMC Mol Biol. 2009 Jan 21;10:2. doi: 10.1186/1471-2199-10-2.

23.

Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor.

Liao JJ, Huang MC, Fast K, Gundling K, Yadav M, Van Brocklyn JR, Wabl MR, Goetzl EJ.

FASEB J. 2009 Jun;23(6):1786-96. doi: 10.1096/fj.08-124891. Epub 2009 Jan 21.

24.

Expression of Aire and the early wave of apoptosis in spermatogenesis.

Schaller CE, Wang CL, Beck-Engeser G, Goss L, Scott HS, Anderson MS, Wabl M.

J Immunol. 2008 Feb 1;180(3):1338-43.

25.

Pvt1-encoded microRNAs in oncogenesis.

Beck-Engeser GB, Lum AM, Huppi K, Caplen NJ, Wang BB, Wabl M.

Retrovirology. 2008 Jan 14;5:4. doi: 10.1186/1742-4690-5-4.

26.

Differentiation and Ig-allele switch in cell line WEHI-231.

Spillmann FJ, Beck-Engeser G, Wabl M.

J Immunol. 2007 Nov 15;179(10):6395-402.

27.

Ig heavy chain promotes mature B cell survival in the absence of light chain.

Geraldes P, Rebrovich M, Herrmann K, Wong J, Jäck HM, Wabl M, Cascalho M.

J Immunol. 2007 Aug 1;179(3):1659-68.

28.

Impairment of alternative splice sites defining a novel gammaretroviral exon within gag modifies the oncogenic properties of Akv murine leukemia virus.

Sørensen AB, Lund AH, Kunder S, Quintanilla-Martinez L, Schmidt J, Wang B, Wabl M, Pedersen FS.

Retrovirology. 2007 Jul 6;4:46.

29.

Retroviral activation of the mir-106a microRNA cistron in T lymphoma.

Lum AM, Wang BB, Li L, Channa N, Bartha G, Wabl M.

Retrovirology. 2007 Jan 25;4:5.

30.

Activation of an oncogenic microRNA cistron by provirus integration.

Wang CL, Wang BB, Bartha G, Li L, Channa N, Klinger M, Killeen N, Wabl M.

Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18680-4. Epub 2006 Nov 22.

31.

Slow, stochastic transgene repression with properties of a timer.

Wang CL, Yang DC, Wabl M.

Genome Biol. 2006;7(6):R47.

32.

A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus.

Glud SZ, Sørensen AB, Andrulis M, Wang B, Kondo E, Jessen R, Krenacs L, Stelkovics E, Wabl M, Serfling E, Palmetshofer A, Pedersen FS.

Blood. 2005 Nov 15;106(10):3546-52. Epub 2005 Jul 28.

33.

Somatic hypermutation and mismatch repair in non-B cells.

Klasen M, Spillmann FJ, Marra G, Cejka P, Wabl M.

Eur J Immunol. 2005 Jul;35(7):2222-9.

34.

Retroviral vectors to monitor somatic hypermutation.

Klasen M, Spillmann FJ, Lorens JB, Wabl M.

J Immunol Methods. 2005 May;300(1-2):47-62.

PMID:
15936027
35.

Hypermutation rate normalized by chronological time.

Wang CL, Wabl M.

J Immunol. 2005 May 1;174(9):5650-4.

36.

Mutational activity in cell line WEHI-231.

Wang CL, Wabl M.

Immunogenetics. 2005 Feb;56(11):849-53. Epub 2004 Dec 18.

PMID:
15605247
37.

Autoreactivity and allelic inclusion in a B cell nuclear transfer mouse.

Gerdes T, Wabl M.

Nat Immunol. 2004 Dec;5(12):1282-7. Epub 2004 Oct 31.

PMID:
15516926
38.

Directed molecular evolution by somatic hypermutation.

Wang CL, Yang DC, Wabl M.

Protein Eng Des Sel. 2004 Sep;17(9):659-64. Epub 2004 Oct 29.

PMID:
15516361
39.
40.

Precise dosage of an endogenous mutagen in the immune system.

Wang CL, Wabl M.

Cell Cycle. 2004 Aug;3(8):983-5. Epub 2004 Aug 16. Review.

PMID:
15254421
42.

DNA acrobats of the Ig class switch.

Wang CL, Wabl M.

J Immunol. 2004 May 15;172(10):5815-21. Review.

43.

Genome-wide somatic hypermutation.

Wang CL, Harper RA, Wabl M.

Proc Natl Acad Sci U S A. 2004 May 11;101(19):7352-6. Epub 2004 Apr 29.

44.

Silent point mutation in DsRed resulting in enhanced relative fluorescence intensity.

Klasen M, Wabl M.

Biotechniques. 2004 Feb;36(2):236-8. No abstract available.

45.

DNA-PKcs function regulated specifically by protein phosphatase 5.

Wechsler T, Chen BP, Harper R, Morotomi-Yano K, Huang BC, Meek K, Cleaver JE, Chen DJ, Wabl M.

Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1247-52. Epub 2004 Jan 20.

47.

The possibility of B-cell-dependent T-cell development.

Keshavarzi S, Rietz C, Simões S, Shih S, Platt JL, Wong J, Wabl M, Cascalho M.

Scand J Immunol. 2003 May;57(5):446-52.

48.

Physical map of the mouse lambda light chain and related loci.

Gerdes T, Wabl M.

Immunogenetics. 2002 Apr;54(1):62-5.

PMID:
11976793
49.

SWAP-70-deficient mast cells are impaired in development and IgE-mediated degranulation.

Gross B, Borggrefe T, Wabl M, Sivalenka RR, Bennett M, Rossi AB, Jessberger R.

Eur J Immunol. 2002 Apr;32(4):1121-8.

50.

Contribution of light chain rearrangement in peripheral B cells to the generation of high-affinity antibodies.

Magari M, Sawatari T, Kawano Y, Cascalho M, Wabl M, Kanayama N, Hikida M, Ohmori H.

Eur J Immunol. 2002 Apr;32(4):957-66.

Supplemental Content

Support Center